Joint stabilisation

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Heparin / LMWH 4 substances
Factor Xa inhibitor (DOAC) 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Centre Hospitalier Universitaire D'Angers Academic
    DALTEPARIN SODIUM; ENOXAPARIN SODIUM; NADROPARIN CALCIUM; RIVAROXABAN; TINZAPARIN SODIUM
    2023-509905-62-00 1 country 2024 n=1,424
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Centre Hospitalier Universitaire D'Angers Academic 1 Phase III 1
New trials by year
2024
1
← All indication landscapes